ClearBridge Investments’s Verona Pharma VRNA Stock Holding History

ClearBridge Investments’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-119,217	Closed	-$12.7M	–	740
2025 Q3	$12.7M	Sell	119,217 -16,582	-12%	-$1.73M	0.01%	471
2025 Q2	$12.8M	Sell	135,799 -119,385	-47%	-$8.84M	0.01%	448
2025 Q1	$16.2M	Sell	255,184 -56,989	-18%	-$3.41M	0.01%	429
2024 Q4	$14.5M	Sell	312,173 -93,568	-23%	-$3.51M	0.01%	481
2024 Q3	$11.7M	Sell	405,741 -78	-0%	-$1.92K	0.01%	517
2024 Q2	$5.87M	Buy	405,819 +150,210	+59%	+$2.19M	﹤0.01%	578
2024 Q1	$4.11M	Buy	255,609 +6,645	+3%	+$115K	﹤0.01%	596
2023 Q4	$4.95M	Buy	+248,964	New	+$3.68M	﹤0.01%	581

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

ClearBridge Investments's VRNA Position: Q4 2025 in Review

ClearBridge Investments sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 119,217 shares — an estimated $12.7M sold.

ClearBridge Investments first reported a position in VRNA in Q4 2023 and held it in 8 quarters. The position peaked at $16.2M in Q1 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

ClearBridge Investments reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
ClearBridge Investments sold 119,217 Verona Pharma shares in Q4 2025, an estimated $12.7M.
ClearBridge Investments first reported a position in Verona Pharma in Q4 2023 and held it in 8 quarters.
ClearBridge Investments's Verona Pharma position peaked at $16.2M in Q1 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on ClearBridge Investments's 13F filing for Q4 2025, filed 11 Feb 2026.